%0 Comparative Study
%T [Update points for the 2022 edition of the European Association for the Study of Liver Diseases Clinical Practice Guidelines for the Management of Hepatic Encephalopathy and comparison with China's 2018 edition guidelines].
%A Zhang TY
%A Sun X
%A Yao YH
%A Jin Q
%A Gan DN
%A Ye YA
%A Li XK
%J Zhonghua Gan Zang Bing Za Zhi
%V 31
%N 9
%D 2023 Sep 20
%M 37872087
暂无%R 10.3760/cma.j.cn501113-20221111-00560
%X The European Association for the Study of Liver Diseases issued the "Clinical Practice Guidelines for the Management of Hepatic Encephalopathy" in 2022, which included recommendations for clinical diagnosis, assessment, treatment, management, and prevention. The Society's "Hepatic Encephalopathy Clinical Practice Guidelines in Chronic Liver Disease," which was last published in 2014, and the "Guidelines for the Diagnosis and Treatment of Hepatic Encephalopathy in Cirrhosis," which the Chinese Society of Hepatology, Chinese Medical Association, released in 2018, have certain differences and updates in terms of comparison to terminology, grading and classification, diagnosis, clinical evaluation and treatment, management, and prevention. Herein, the updated points of this guideline and the differences between it and our nation's guidelines are summarized in order to refine and understand the guiding role of the new version of the guideline for the clinical treatment of hepatic encephalopathy and provide aid for standardizing clinical diagnosis and treatment.<BR>2022年欧洲肝病学会发布了《肝性脑病管理临床实践指南》，为肝性脑病的临床诊断、评估、治疗、管理与预防提出推荐意见。与该学会末次发布于2014年的《慢性肝病肝性脑病临床实践指南》及2018年中华医学会肝病学分会《肝硬化肝性脑病诊疗指南》相比，该指南在肝性脑病的术语运用、分级分类、诊断、临床评估与治疗、临床管理与预防等方面有一定区别和更新。现归纳此指南更新亮点及其与我国指南的区别，以期细化理解新版指南对于肝性脑病的临床治疗的指导作用，为规范肝性脑病的临床诊治提供帮助。.